Partnerships & Mergers

The partnership directly supports Dubai’s D33 Economic Agenda and aims to establish the emirate as a global leader in HealthTech innovation.

The IMARA–BC initiative targets women aged 40 and above, encouraging them to undergo routine screening so that cancer is detected at stage one or two, when treatment is most effective.

The partnership will provide JOOTRH with dedicated advanced facilities, including project-specific space for an Advanced Pathology Lab within the hospital.

The deal aimed to combine Lensar’s innovative cataract surgery technologies with Alcon’s existing portfolio, potentially creating a dominant force in the femtosecond laser-assisted cataract surgery market.

The meeting represents part of the Egyptian Drug Authority’s ongoing efforts to engage with leading international pharmaceutical companies and promote strategic partnerships that support industry development.

The partnership will bring select consultant vascular and endovascular surgeons from Sir Ganga Ram Hospital’s IVES to C37’s Dubai facility.

This arrangement strengthens an existing partnership between the two pharmaceutical giants, who already collaborate on manufacturing the mpox vaccine.

The summit concluded with stakeholders committing to strengthen surveillance systems, build diagnostic capacity, and expand access to treatment throughout the continent.

Through strategic partnerships similar to the Pharmalink agreement, the medication has already reached patients in China, Hong Kong, Japan, and various Latin American markets.

The network will create a nationwide digital infrastructure that enhances diagnostic accuracy while supporting more effective treatment planning for patients throughout Egypt.